FDA Shows Limited Progress In Managing DTC Workload, GAO Tells House Panel
This article was originally published in The Pink Sheet Daily
House Energy and Commerce panel hearing focuses on DTC ads for Vytorin, Lipitor and Procrit.
You may also be interested in...
Although the campaign had been running for years with no problems, FDA instructed Merck/Schering-Plough to revise the Vytorin DTC ads even as the agency publicly affirmed the utility of the drug.
Congressional probe of direct-to-consumer marketing sparks firm's change of heart on anti-cholesterol drug.
A Government Accountability Office report, released Dec. 14, calls for improvements in FDA’s oversight of direct-to-consumer advertising.